TD Cowen Maintains Outperform on GoodRx Holdings, Raises Price Target to $14
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Charles Rhyee maintains an Outperform rating on GoodRx Holdings (NASDAQ:GDRX) and raises the price target from $12 to $14.
March 01, 2024 | 1:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Charles Rhyee maintains an Outperform rating on GoodRx Holdings and raises the price target from $12 to $14.
The increase in price target by a reputable analyst suggests a positive outlook on the company's future performance, likely leading to increased investor confidence and a potential short-term rise in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100